Latest Headlines
-
eLabNext Boosts Sample Management With Full LabTAG Compatibility For Enhanced Identification And Tracking
10/17/2024
Today, eLabNext, an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic Lab Notebook (ELN), announced that its platform is now compatible with LabTAG’s, industry-leading laboratory labels and identification products, available through GA International.
-
Luminate Health Leads Direct-To-Consumer Lab Testing Market, Expanding Laboratory Reach, Accessibility, And Growth
10/17/2024
Luminate Health, a leader in healthcare technology solutions for the clinical laboratory and diagnostics market, has seen unparalleled success with the adoption of its innovative Direct-to-Consumer (DTC) lab testing platform.
-
LabTAG And eLabNext Partner To Enhance Sample Management & Identification
10/16/2024
GA International, a global leader in laboratory identification solutions, announced today that its industry-leading LabTAG laboratory labels are now fully compatible with eLabNext’s Digital Laboratory Platform.
-
Lucid Diagnostics Receives Notice Of Allowance For Key Patent Underlying Its EsoGuard Esophageal DNA Test
10/15/2024
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application covering its proprietary method of using methylation of the cyclin-A1 (CCNA1) gene to help detect esophageal precancer and cancer, a key component of its EsoGuard® Esophageal DNA Test.
-
Sapio Sciences Enhances Bioanalysis LIMS And ELN With Advanced Immunogenicity Capabilities
10/15/2024
Sapio Sciences, the science-aware lab informatics platform, today announced the addition of new immunogenicity bioanalysis features to its industry-leading lab informatics platform.
-
Germfree Acquires Arcoplast To Expand Turnkey Facility Solutions And Expand Market Reach Through Superior Architectural Finishes
10/14/2024
Germfree, a pioneering leader in modular and mobile cleanroom infrastructure, equipment and services, today announced the acquisition of Arcoplast, maker of the leading seamless primary barrier cleanroom wall and ceiling system for Life Science applications and more.
-
MyOme And Broad Clinical Labs To Support Southern Research Program To Bring Genetics-Driven Health Insights To Alabamians Free Of Charge
10/14/2024
MyOme, Inc., a leading clinical genetics innovation company, and Broad Clinical Labs (BCL), a world expert in whole genome sequencing (WGS) are announcing a collaboration to support the Southern Research (SR) program, Catalyst.
-
BD Announces New Robotics Solution to Automate, Standardize Single-Cell Research
10/14/2024
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits that will enable automation to ensure greater consistency and increased efficiency of large-scale, single-cell discovery studies.
-
Waters New Bioseparations Tools Accelerate And Improve Development Of RNA-Based Vaccines And Therapies Using LC-MS Analysis
10/14/2024
Waters Corporation (NYSE: WAT) today introduced a comprehensive set of sample preparation enzymes, reagents, and waters_connect software that simplify sequence and modification confirmation of large molecule RNA therapeutics using liquid chromatography-mass spectrometry (LC-MS) analysis.
-
Fullscript Acquires Rupa Health
10/10/2024
Fullscript, a leading healthcare platform for whole person care, today announced the acquisition of Rupa Health, a company that helps practitioners order, track and manage more than 3,000 laboratory tests in a single interface.